港股異動 | 美團(3690.HK)創近兩個半月新高 連續4天獲南向資金淨買入
格隆匯6月25日丨美團(3690.HK)漲2.79%,報323.8港元,股價創近兩個半月新高,最新總市值19789億港元。

6月24日上榜的港股通成交活躍股中,美團-W通過港股通渠道成交金額為20.66億港元,淨買入金額為8.62億港元,不僅如此,該股已連續4日出現成交淨買入,累計淨買入金額16.36億港元。
美團創辦人、首席執行官王興在股東周年大會(AGM)表示,對社區電商的長期發展充滿信心,相信社區電商有很大的市場空間,可真正幫助集團進入商品電商和更廣泛的消費零售市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.